Plasma cell acid phosphatase in multiple myeloma.

نویسنده

  • P Musto
چکیده

In a recent issue of Blood, Saeed et all reported about the prognostic significance of plasma cell acid phosphatase (PCAP) in a large number of patients with multiple myeloma, showing that a low PCAP score (< 130) at diagnosis might recognize a subgroup of myelomatous patients with poor prognosis. I believe that such findings are quite surprising in view of the previously published cumulative data on this topic, including personal experience: and of some biologic considerations. The same group had found a direct correlation between a high PCAP score and “active” phases of disease in selected myelomatous patients3; our studies had confirmed these observations.’ In addition, such as emerged also in the report in discussion, MGUS and “reactive” bone marrow plasmocytosis usually evidence lower PCAP activity than that measured in “overt” myeloma; overlaps may occur, but only at low levels of PCAP score. Finally, in multiple myeloma, a direct correlation between PCAP and plasma cell proliferative activity (one of the most important prognostic factors in this disease), has been r e ~ o r t e d . ~ . ~ All of these findings indicate a possible relationship between high levels of PCAP and intrinsic biologic “aggressiveness” of myeloma cells, a fact that seems to contrast with the conclusions of Saeed et al. Even when we have recently reevaluated PCAP in 102 cases of multiple myeloma adopting the modified scoring method proposed by these investigators, we obtained a good correlation between high PCAP score at diagnosis and poor prognosis (PCAP score >200 v 1200: median overall survival 18 v 59 months, respectively, P < ,001). In particular, increased levels of PCAP were detected in three cases of plasma cell leukemia with very short survival. As reported previously: we found that the only group of myelomatous subjects who showed a poor clinical outcome associated with a constantly low PCAP score was confined to those patients with a high percentage (>40%) of “flaming” plasma cells. We speculated that the large amount of glycoproteins that is present in these cells could mask the positivity of the cytochemical reaction or, in turn, that the wider cytoplasm extension could lead to a lower total score for PCAP. In this setting, it is noteworthy that the prognosis of multiple myeloma with “flaming” morphologic features has sometimes been reported to be unfavorable (and overall survival of such cases in our series was significantly lower than that of other patients). It would be of interest to know whether Saeed et a1 looked at this phenomenon. In conclusion, in view ofthe contrasting data at present time available on this topic, 1 believe that the clinical significance of PCAP in multiple myeloma, if any, remains unclear.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

An Unusual Presentation of Plasma Cell Leukemia with Undiagnosed Multiple Myeloma

A 54 year old man with history of cardiomyopathy and chronic fibrillation first presented with bloody diarrhea. Then during the assessment of his abnormal lab. data revealed cast nephropathy in renal biopsy, gamma peak in protein electrophoresis and fine lytic lesions in skull graphy. His bone marrow asp...

متن کامل

Non Secretory Multiple Myeloma With HCV Infection: A Rare Case Entity

Multiple Myeloma is a neoplasm of B cell lineage characterized by excessive proliferation of abnormal plasma cells. It is characterized by a clinical  pentad of 1) anemia, 2) a monoclonal protein in the serum or the urine or both, 3) bone leisons and or bone pain, 4) hypercalcemia >11.5g/dl and 5) renal insufficiency. Non secretory multiple myeloma is a rare variant of the classic form of multi...

متن کامل

Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells Inhibit CD8+ T Cell Function in a Process that May Implicate Fibroblast Activation Protein α

Background: Multiple myeloma (MM) is a malignant plasma cell proliferative disorder with limited immunotherapy treatment because of T cell dysfunction. Objective: To investigate the immunomodulatory function of bone marrow mesenchymal stromal cells (MM-BMSCs) on CD8+ T cells. Methods: Proliferation and cytotoxicity were detected by c...

متن کامل

CD93 is Selectively Expressed on Human Myeloma Cells but Not on B Lymphocytes

Background: CD93 has originally been known as a C1q receptor, and many studies have demonstrated that CD93 is expressed on hematopoietic stem cells, B cell progenitors, myeloid and monocytic cells. Moreover, CD93 is shown to be expressed on long-lived plasma cells, and CD93 deficient-mice display an impairment in plasma cell development. Objective: To investiga...

متن کامل

Myeloma bone marrow acid phosphatase staining: a correlative study of 38 patients.

Acid phosphatase (AP) activity of plasma cells was studied in 38 patients with multiple myeloma (MM). The average activity per cell was strong (mean score = 2.42; maximum score = 4) and the percentage of positive cells was greater than 90% in over 71% of patients. The average AP activity per cell was higher prior to treatment (3.06 +/- 0.53) compared to relapse (2.48 +/- 0.77) and remission (1....

متن کامل

Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study.

In 1982 a randomized trial of either alternating or syncopated VMCP/VBAP regimens for the treatment of active multiple myeloma was begun (Southwest Oncology Group Study 8229/30). A concurrent investigation was undertaken to evaluate the clinical importance and significance of cytochemically stainable plasma cell acid phosphatase (AP) and beta-glucuronidase enzymes (BG). Pretreatment bone marrow...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Blood

دوره 81 3  شماره 

صفحات  -

تاریخ انتشار 1993